Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod

Magro, Fernando; Peyrin‐Biroulet, Laurent; E. Sands, Bruce; Danese, Silvio; Jairath, Vipul; Goetsch, Martina; Bhattacharjee, Abhishek; Wu, Joseph; Branquinho, Diogo; Modesto, Irene; G. Feagan, Brian

doi:10.1016/j.cgh.2024.07.010

Public

Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod

Published in Clinical Gastroenterology and Hepatology • Jul 31, 2024

Authors:

Fernando Magro

Laurent Peyrin‐Biroulet

Bruce E. Sands

Abstract

BACKGROUND & AIMS: receptor modulator for the treatment of moderately to severely active UC. This post-hoc analysis of the ELEVATE UC program evaluated the efficacy of etrasimod according to histologic and composite (histologic/endoscopic/symptomatic) endpoints and examined their prognostic value. M...

Subject

Medicine

Ulcerative colitis

Gastroenterology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!